Oxybuprocaine

When ATH:
S01HA02

Characteristic.

The local anesthetic from the group of esters for use in ophthalmology.

Pharmacological action.
Mestnoanesteziruyuschee.

Application.

Local anesthesia in ophthalmology: intraocular pressure measurement (tonometry); Gonioscopy; Diagnostic scraping the conjunctiva; extraction of foreign bodies and sutures from the cornea and conjunctiva; short-term surgical interventions on the cornea and conjunctiva.

Contraindications.

Hypersensitivity, corneal erosion.

Pregnancy and breast-feeding.

During pregnancy and breastfeeding may use to destination the attending physician, if the effect of therapy outweighs the potential risk to the fetus and child (there is not enough experience in the application).

Side effects.

Short tingling, burning sensation and conjunctival hyperemia; allergic reactions; rarely is keratitis.

Cooperation.

The literature describes the positive or negative effects in the simultaneous introduction into the conjunctival cavity oxybuprocaine other eye drops. Noted, oxybuprocaine that theoretically can reduce the antibacterial activity of sulfonamides.

Overdose.

There are no data on overdose.

Dosing and Administration.

Locally, instilled into the conjunctival sac 1 drop; for diagnostic procedures — 1-2 times, for long-term anesthesia (to 1 no) in ambulatory surgical preparation can be further instilled 3-4 times at intervals of 4-5 minutes.

Precautions.

Use only for instillation into the conjunctival sac; Do not use for injection. Not intended for long-term therapy in treatment of eye diseases.

Adequate experience in children is not, can be used for other purposes doctor.

It should be taken into account, Prolonged, multiple and long-term use can lead to clouding of the cornea (As in the case of other local anesthetics). During anesthesia should protect your eyes from dust, irritating chemical effects, bacterial contamination. Do not touch your eyes before the end of anesthesia.